Your Health, We Care
Palbociclib is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with:
• an aromatase inhibitor as initial endocrine-based therapy; or
• fulvestrant in patients with disease progression following endocrine therapy.
FDA，2022.12
LuciusVersionofPalbociclib:DosageandAdministration,Indications,PrecautionsIndicationCapivasertib is ···【more】
Recommended：1342025-05-12
Lucius Version of Palbociclib: Dosage and Administration, Indications, PrecautionsIndicationsPalboci···【more】
Recommended：1662025-02-12
What is Palbociclib?Palbociclib is an oral anticancer drug whose active ingredient is palbociclib. It is a targeted therapy specifically used to treat certain types of advanced bre···【more】
Article source：Lucius LaosRelease date：2026-05-13Recommended：50
Indications and Combination Regimens of PalbociclibPalbociclib 125 mg capsules and tablets are indicated for the treatment of hormone receptor-positive (HR+), human epidermal growt···【more】
Article source：Lucius LaosRelease date：2026-05-12Recommended：48
Applicable for the treatment of adult patients with advanced or metastatic breast cancer who are hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-···【more】
Article source：Lucius LaosRelease date：2026-01-05Recommended：102
LuciusVersionofPalbociclib:DosageandAdministration,Indications,PrecautionsIndicationCapivasertib is a kinase inhibitor. In combination with fulvestrant, it is indicated for the tre···【more】
Article source：Lucius LaosRelease date：2025-12-05Recommended：134
Lucius Version of Palbociclib: Dosage and Administration, Indications, PrecautionsIndicationsPalbociclib is a kinase inhibitor indicated for the treatment of adult patients with ho···【more】
Article source：Lucius LaosRelease date：2025-12-02Recommended：166
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
